Medicum Centrum UAB
- Address
- Dariaus Ir Gireno G. 28a, Taurages R. Sav., 72250 Tauragė, Lithuania
Medicum Centrum UAB - Neurology and Migraine Research
Medicum Centrum UAB is a specialized clinical research center with expertise in neurological disorders, particularly focused on advancing therapeutic solutions for patients with complex migraine conditions. The center demonstrates particular strength in conducting dose-finding studies and evaluating novel preventative treatments for patients who have experienced inadequate response to conventional migraine therapies.
- Migraine prevention and treatment-resistant migraine management
- Dose-optimization studies for neurological therapeutics
- Efficacy evaluation of innovative migraine preventative medications
The facility specializes in working with refractory patient populations who have not achieved adequate relief from prior preventative treatments, contributing valuable data to the development of next-generation migraine therapies. Through rigorous clinical trial methodology, Medicum Centrum UAB plays an important role in advancing evidence-based approaches to chronic neurological pain management.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 79 other sites in Lithuania
Therapeutic Area Benchmark — Lithuania
Select a therapeutic area to compare against other sites in Lithuania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Lithuania
Market Share
Country: Lithuania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Medicum Centrum UAB
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of Lu AG09222 for Migraine Prevention in Adults with Episodic and Chronic Migraine | H. Lundbeck A/S | Phase II | Not Recruiting | Aug 2024 | Mar 2026 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Lu Ag09222 | 1 | Unknown | 2024-08-14 | 2024-08-14 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.